This trial is testing whether the drug Dexmedetomidine can help manage episodes of agitation among patients with schizophrenia.
- Schizoaffective Disorder
6 Primary · 3 Secondary · Reporting Duration: Assessed prior to dosing, throughout study drug administration, and up to one week after drug administration
2 Treatment Groups
1 of 2
1 of 2
50 Total Participants · 2 Treatment Groups
Primary Treatment: Order 1 · Has Placebo Group · Phase 2
Who is running the clinical trial?
Age 18 - 65 · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Who are the ideal candidates for this clinical trial?
"This psychiatric study is seeking around 50 individuals who have been diagnosed with schizophrenia and are between 18-65 years old." - Anonymous Online Contributor
Does this research include adults aged 45 and up?
"This study only allows patients that fall within a certain age range, being over 18 years old and younger than 65." - Anonymous Online Contributor
What condition is Order 1 typically employed against?
"Order 1 can be used to treat various diseases, including but not limited to ventilations, mechanical, and cyclic vomiting syndrome." - Anonymous Online Contributor
Is Order 1 a common medication studied in clinical trials?
"At this moment, there are 119 ongoing studies concerning Order 1 with 25 of them in Phase 3. The majority of research concerning Order 1 is being conducted in Karachi, Sindh; however, there are 221 total locations running studies for Order 1." - Anonymous Online Contributor
Are researchers still able to enroll new participants in this trial?
"From the information available on clinicaltrials.gov, it appears that this clinical trial is still recruiting patients. This study was first posted on March 9th, 2020, and was edited on July 22nd, 2022. They are looking for 50 patients total from 1 site." - Anonymous Online Contributor
What level of risk is associated with Order 1 for human users?
"Order 1's safety was evaluated as a 2. This is because, while there is data supporting safety, there is no information suggesting that Order 1 is an effective medication." - Anonymous Online Contributor